TEW-7197 첫 용량 투여에서 안전성 확인, 용량증대 결정
Oct 21, 2015MILESTONESHit 241
On 14th of Oct. 2014 (13th in USA) SMC reviewed safety of the first cohort of TEW-7197 (NCT02160106) and did not find any drug-related toxicity. The committee recommended a dose escalation to the next level. Three clinical sites in the USA started recruitment of patients with solid tumor for the second cohort.
|Previous||ANRT 와 협약|
|Next||메드팩토, MSD와 면역항암제 병용 투여 임상 계약|